The Right TraderBeta

NEKTAR THERAPEUTICS

NKTR
—
Advanced chart & tools →
NEKTAR THERAPEUTICSNKTR
$0.00
+$0.00(+NaN%)Past Year
$0.00$0.00$0.00$0.00
Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap
—
P/E ratio
—
EPS (diluted)
$-9.73
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$55.23M
Net income
$-164.08M
Net margin
-297.1%
Gross margin
1.1%

Dividends & financials

NEKTAR THERAPEUTICS (NKTR) reported revenue of $55.23M and net income of $-164.08M, or $-9.73 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.